Literature DB >> 28619846

Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis.

Bob de Rooij1, Roel Polak1, Lieke C J van den Berk1, Femke Stalpers1, Rob Pieters2, Monique L den Boer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28619846      PMCID： PMC5622868          DOI： 10.3324/haematol.2016.159517

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

Authors:  A Peled; I Petit; O Kollet; M Magid; T Ponomaryov; T Byk; A Nagler; H Ben-Hur; A Many; L Shultz; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

2.  Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.

Authors:  Madeleine Duvic; Lauren C Pinter-Brown; Francine M Foss; Lubomir Sokol; Jeffrey L Jorgensen; Pramoda Challagundla; Karen M Dwyer; Xiaoping Zhang; Michael R Kurman; Rocco Ballerini; Li Liu; Youn H Kim
Journal:  Blood       Date:  2015-01-20       Impact factor: 22.113

3.  B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment.

Authors:  Roel Polak; Bob de Rooij; Rob Pieters; Monique L den Boer
Journal:  Blood       Date:  2015-08-21       Impact factor: 22.113

4.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Authors:  Joji Fujisaki; Juwell Wu; Alicia L Carlson; Lev Silberstein; Prabhakar Putheti; Rafael Larocca; Wenda Gao; Toshiki I Saito; Cristina Lo Celso; Hitoshi Tsuyuzaki; Tatsuyuki Sato; Daniel Côté; Megan Sykes; Terry B Strom; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Authors:  Neal Flomenberg; Steven M Devine; John F Dipersio; Jane L Liesveld; John M McCarty; Scott D Rowley; David H Vesole; Karin Badel; Gary Calandra
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

6.  Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.

Authors:  Elizabeth S Nakasone; Hanne A Askautrud; Tim Kees; Jae-Hyun Park; Vicki Plaks; Andrew J Ewald; Miriam Fein; Morten G Rasch; Ying-Xim Tan; Jing Qiu; Juwon Park; Pranay Sinha; Mina J Bissell; Eirik Frengen; Zena Werb; Mikala Egeblad
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

Review 7.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Authors:  J A Burger; A Peled
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

8.  Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.

Authors:  Lieke C J van den Berk; Arian van der Veer; Marieke E Willemse; Myrte J G A Theeuwes; Mirjam W Luijendijk; Wing H Tong; Inge M van der Sluis; Rob Pieters; Monique L den Boer
Journal:  Br J Haematol       Date:  2014-04-04       Impact factor: 6.998

9.  Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.

Authors:  R Parameswaran; M Yu; M Lim; J Groffen; N Heisterkamp
Journal:  Leukemia       Date:  2011-04-12       Impact factor: 11.528

10.  Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.

Authors:  Masao Nakagawa; Roland Schmitz; Wenming Xiao; Carolyn K Goldman; Weihong Xu; Yandan Yang; Xin Yu; Thomas A Waldmann; Louis M Staudt
Journal:  J Exp Med       Date:  2014-12-08       Impact factor: 14.307
View more
  8 in total

1.  Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.

Authors:  Chao Ma; Matthew T Witkowski; Jacob Harris; Igor Dolgalev; Sheetal Sreeram; Weiyi Qian; Jie Tong; Xin Chen; Iannis Aifantis; Weiqiang Chen
Journal:  Sci Adv       Date:  2020-10-30       Impact factor: 14.136

Review 2.  Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.

Authors:  Peter Valent; Irina Sadovnik; Gregor Eisenwort; Harald Herrmann; Karin Bauer; Niklas Mueller; Wolfgang R Sperr; Daniel Wicklein; Udo Schumacher
Journal:  Semin Cancer Biol       Date:  2019-08-10       Impact factor: 15.707

Review 3.  The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.

Authors:  Erica Dander; Chiara Palmi; Giovanna D'Amico; Giovanni Cazzaniga
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 4.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

5.  Harnessing immunotherapy for pediatric T-cell malignancies.

Authors:  Caroline Diorio; David T Teachey
Journal:  Expert Rev Clin Immunol       Date:  2020-02-27       Impact factor: 5.124

6.  Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.

Authors:  Juan Carlos Balandrán; José Dávila-Velderrain; Antonio Sandoval-Cabrera; Gabriela Zamora-Herrera; Vanessa Terán-Cerqueda; Lilia Adela García-Stivalet; José Alejandro Limón-Flores; Erick Armenta-Castro; Aurora Rodríguez-Martínez; Bertha Alicia Leon-Chavez; Verónica Vallejo-Ruiz; Duane C Hassane; Sonia Mayra Pérez-Tapia; Vianney Ortiz-Navarrete; Monica L Guzman; Rosana Pelayo
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

Review 7.  The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells?

Authors:  Alireza Goodarzi; Mohsen Valikhani; Fatemeh Amiri; Armita Safari
Journal:  Cell Commun Signal       Date:  2022-03-02       Impact factor: 5.712

Review 8.  Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche.

Authors:  Alessandra Fallati; Noemi Di Marzo; Giovanna D'Amico; Erica Dander
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.